Intersect ENT (XENT) Tops Q3 EPS by 5c

Intersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.22), $0.05 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $17.84 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• AeroVironment restates quarterly financials, citing $89M goodwill error